Ingmar Lax
Overview
Explore the profile of Ingmar Lax including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindback E, Jirf K, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
117(5):1222-1231.
PMID: 37423292
Purpose: Stereotactic body radiation therapy for tumors near the central airways implies high-grade toxic effects, as concluded from the HILUS trial. However, the small sample size and relatively few events...
2.
Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174046
Previous studies on dose-escalated radiotherapy in head and neck cancer have shown mixed results, and it is not established which patients would benefit from dose escalation. Further, while dose escalation...
3.
Mercke C, Wickart-Johansson G, Sjodin H, Farrajota Neves da Silva P, Alexandersson von Dobeln G, Margolin G, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174008
Methods: Eligible patients in this multicenter, randomized, controlled, phase 2 trial had p16-positive locoregionally advanced SCCHN. Patients were randomized in a 1:1 ratio to either RT with cetuximab (arm B)...
4.
Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S
Radiat Oncol
. 2023 Apr;
18(1):65.
PMID: 37029424
Background: Local recurrence is the most common pattern of failure in head and neck cancer. It can therefore be hypothesised that some of these patients would benefit from an intensified...
5.
Karlsson B, Jokura H, Yang H, Yamamoto M, Martinez-Alvarez R, Kawagishi J, et al.
Neurosurgery
. 2022 Oct;
91(6):920-927.
PMID: 36219806
Background: Knowledge about the natural course of brain arteriovenous malformations (AVMs) have increased during the past 20 years, as has the number of AVMs treated, especially larger ones. It is...
6.
Lindberg K, Lax I, Karlsson K, Lewensohn R
J Thorac Oncol
. 2021 Sep;
16(10):e81-e82.
PMID: 34561040
No abstract available.
7.
Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Bornedal S, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34202135
Re-irradiation in head and neck cancer is challenging, and cumulative dose constraints and dose/volume data are scarce. In this study, we present dose/volume data for patients re-irradiated for head and...
8.
Karlsson K, Lax I, Lindback E, Grozman V, Lindberg K, Wersall P, et al.
Phys Med
. 2021 Jun;
88:53-64.
PMID: 34175747
Introduction: Dose-response relationships for local control of lung tumours treated with stereotactic body radiotherapy (SBRT) have proved ambiguous, however, these have been based on the prescribed or planned dose. Delivered...
9.
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersall P, et al.
J Thorac Oncol
. 2021 Apr;
16(7):1200-1210.
PMID: 33823286
Introduction: Stereotactic body radiation therapy of thoracic tumors close to the central airways implies risk of severe toxicity. We report a prospective multicenter phase 2 trial for tumors located less...
10.
Grozman V, Onjukka E, Wersall P, Lax I, Tsakonas G, Nyren S, et al.
Acta Oncol
. 2021 Jan;
60(3):305-311.
PMID: 33448899
Background And Purpose: Stereotactic body radiotherapy (SBRT) for tumours ≥5 cm is poorly studied and its utility and feasibility is uncertain. We here report the Karolinska experience of SBRT in...